NL7703124A - PHARMACEUTICAL ACTIVE COMPOUNDS FOR THE CONTROL OF SCHIZOPHRENIA SYMPTOMS, METHOD FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE SUBSTANCE AND PHARMACEUTICAL PREPARATION FOR THE CONTROL OF SCHIZOPHRENIA SYMTOMS. - Google Patents

PHARMACEUTICAL ACTIVE COMPOUNDS FOR THE CONTROL OF SCHIZOPHRENIA SYMPTOMS, METHOD FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE SUBSTANCE AND PHARMACEUTICAL PREPARATION FOR THE CONTROL OF SCHIZOPHRENIA SYMTOMS.

Info

Publication number
NL7703124A
NL7703124A NL7703124A NL7703124A NL7703124A NL 7703124 A NL7703124 A NL 7703124A NL 7703124 A NL7703124 A NL 7703124A NL 7703124 A NL7703124 A NL 7703124A NL 7703124 A NL7703124 A NL 7703124A
Authority
NL
Netherlands
Prior art keywords
pharmaceutical
control
preparation
schizophrenia
compounds
Prior art date
Application number
NL7703124A
Other languages
Dutch (nl)
Original Assignee
Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/772,851 external-priority patent/US4146614A/en
Application filed by Michigan State filed Critical Michigan State
Publication of NL7703124A publication Critical patent/NL7703124A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7703124A 1976-03-23 1977-03-23 PHARMACEUTICAL ACTIVE COMPOUNDS FOR THE CONTROL OF SCHIZOPHRENIA SYMPTOMS, METHOD FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE SUBSTANCE AND PHARMACEUTICAL PREPARATION FOR THE CONTROL OF SCHIZOPHRENIA SYMTOMS. NL7703124A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66952676A 1976-03-23 1976-03-23
US05/772,851 US4146614A (en) 1976-03-23 1977-02-28 Threonyl-valyline leucine containing peptides and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
NL7703124A true NL7703124A (en) 1977-09-27

Family

ID=27100128

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7703124A NL7703124A (en) 1976-03-23 1977-03-23 PHARMACEUTICAL ACTIVE COMPOUNDS FOR THE CONTROL OF SCHIZOPHRENIA SYMPTOMS, METHOD FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE SUBSTANCE AND PHARMACEUTICAL PREPARATION FOR THE CONTROL OF SCHIZOPHRENIA SYMTOMS.

Country Status (13)

Country Link
JP (1) JPS52142015A (en)
AU (1) AU510679B2 (en)
CA (1) CA1103239A (en)
DE (1) DE2712781A1 (en)
DK (1) DK125177A (en)
FR (1) FR2351954A1 (en)
GB (1) GB1561247A (en)
GR (1) GR63642B (en)
LU (1) LU76998A1 (en)
NL (1) NL7703124A (en)
NO (1) NO771031L (en)
NZ (1) NZ183627A (en)
SE (1) SE7702925L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
JPH03236315A (en) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd Antipsychotic agent

Also Published As

Publication number Publication date
AU510679B2 (en) 1980-07-10
CA1103239A (en) 1981-06-16
DE2712781A1 (en) 1977-10-06
GR63642B (en) 1979-11-27
AU2317477A (en) 1978-09-14
NO771031L (en) 1977-09-26
FR2351954A1 (en) 1977-12-16
LU76998A1 (en) 1977-10-03
GB1561247A (en) 1980-02-13
SE7702925L (en) 1977-09-24
DK125177A (en) 1977-09-24
JPS52142015A (en) 1977-11-26
NZ183627A (en) 1980-02-21
FR2351954B1 (en) 1980-03-28

Similar Documents

Publication Publication Date Title
NL7907583A (en) HETEROCYCLIC COMPOUNDS, IN PARTICULAR INDOOL COMPOUNDS, METHODS FOR PREPARING THE SAME, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT.
NL8103768A (en) HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT.
NL7708741A (en) PROCESS FOR THE PREPARATION OF PROSTANIC ACID DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AS AN ACTIVE COMPONENT.
NL190844C (en) Sulfonium compounds, processes for the preparation of these compounds and pharmaceutical preparations containing these compounds.
NL7703729A (en) PROCESS FOR THE PREPARATION OF ANTHELMINTICA POUR-ON PREPARATIONS.
NL7709697A (en) METHOD FOR PREPARING THIAZOLIDINE DERIVATIVES, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT.
NL7603193A (en) PROCESS FOR THE PREPARATION OF ACYCLIC, ALICYCLIC AND AROMATIC N-SUBSTITUATED HALOGEN-2 -PYRROLIDINONES WITH HERBICIDE ACTION AND HERBICIDE PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7700379A (en) PROCESS FOR PREPARING ANTHRACYCLINEGLYCOSIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7706064A (en) PROCESS FOR THE PREPARATION OF HETEROCYCLICAL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7707936A (en) METHOD FOR THE PRESERVATION OF BASIC PHARMACEUTICAL PREPARATIONS.
NL7713470A (en) PROCESS FOR THE PREPARATION OF 2-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THE ACID ADDITION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7712220A (en) NEW AMINOPROPANOL DERIVATIVES, PROCESS FOR THE PREPARATION OF SUCH DERIVATIVES AND MEDICINAL PRODUCTS WITH THESE DERIVATIVES AS AN ACTIVE COMPOUND.
NL167692B (en) METHOD FOR PREPARING ANOREXICALLY ACTIVE PREPARATIONS; PRODUCTS OBTAINED THEREOF, AND METHOD FOR PREPARING ANOREXICALLY ACTIVE COMPOUNDS.
NL7610480A (en) PROCESS FOR THE PREPARATION OF HYPOLIPEMIC COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT.
NL7701832A (en) PROCEDURE FOR PREPARING AMINOALKYL-PYRROLOBENZOXAZALKANES CONTAINING THESE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS AND THEIR USE AS ANALGETICS.
NL7708982A (en) METHOD FOR PREPARING DIHYDRO-OXO-NICOTINIC ACIDS, AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND AS AN ACTIVE COMPONENT.
NL7711414A (en) PROCESS FOR THE PREPARATION OF N-SUBSTITUTED LACTAMS, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT.
NL7707150A (en) PROCESS FOR THE PREPARATION OF 2-LOWER ALKYL-7-SUBSTITUATED-2 OR 3-CEFEM-4-CARBONIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7702180A (en) PROCESS FOR THE PREPARATION OF 9-SUBSTITUTED -8-AZAPURINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL188944C (en) METHOD FOR PREPARING OMEGA-AMINO-KOXYBENZENE DERIVATIVES AND METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEIR USE AS AN ACTIVE COMPOUND
NL7701833A (en) PROCEDURE FOR PREPARING PYRROLOBEN ZOXAZALKANES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS, AND TREATMENT WITH THESE PHARMACEUTICAL PREPARATIONS.
NL7412302A (en) PROCESS FOR THE PREPARATION OF PYRAZOLIUM COMPOUNDS AND HERBICIDE PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7703124A (en) PHARMACEUTICAL ACTIVE COMPOUNDS FOR THE CONTROL OF SCHIZOPHRENIA SYMPTOMS, METHOD FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE SUBSTANCE AND PHARMACEUTICAL PREPARATION FOR THE CONTROL OF SCHIZOPHRENIA SYMTOMS.
NL7709092A (en) PROCESS FOR THE PREPARATION OF CEPHALOSPORIN COMPOUNDS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7712401A (en) PROCEDURE FOR THE PREPARATION OF PREPARATIONS FOR CONTROL OF HARMFUL ORGANISMS.

Legal Events

Date Code Title Description
BV The patent application has lapsed